<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>William Harvey Research Institute</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A"><gtr:id>2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A</gtr:id><gtr:name>Missouri University of Science and Tech</gtr:name><gtr:address><gtr:line1>Missouri University of Science and Tech</gtr:line1><gtr:line2>1870 Miner Circle</gtr:line2><gtr:line4>Rolla</gtr:line4><gtr:line5>Missouri</gtr:line5><gtr:postCode>MO 65409</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A7683F3E-5CBA-4737-98F4-D6F28E88B9A9"><gtr:id>A7683F3E-5CBA-4737-98F4-D6F28E88B9A9</gtr:id><gtr:firstName>Teng-teng</gtr:firstName><gtr:surname>Chung</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700581"><gtr:id>B30622F7-51F2-468C-B496-C133A9D3B202</gtr:id><gtr:title>Functional analysis of naturally occurring mutations of the ACTH receptor and identification of trafficking defects</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700581</gtr:grantReference><gtr:abstractText>The adrenal gland produces several hormones that regulate body function. One of these hormones called cortisol is essential for survival. Cortisol is directly regulated by another hormone called ACTH produced by the pituitary gland in the brain. ACTH acts directly on a protein on the adrenal gland surface called the ACTH receptor. Mutations in the ACTH receptor gene are believed to cause the inherited syndrome known as Familial Glucocorticoid Deficiency, and a large number of such mutations have now been identified in this disease. This project will investigate the consequences of these mutations on the receptor and indicate whether they are indeed the cause of the disease and, if so, in what way they interfere with receptor function. In public health terms, the study of mutant receptors causing this disease will reveal aspects of the mechanism of this receptor and potentially of other related receptors such as the MC4 receptor which is involved in appetite regulation and is associated with human obesity.</gtr:abstractText><gtr:technicalSummary>Aim: To characterise the defects in function of naturally occurring ACTH receptor mutations that give rise to Familial Glucocorticoid Deficiency. 

Objective:
Familial Glucocorticoid Deficiency (FGD) is an autosomal recessive disorder caused in part by mutations in the ACTH receptor (melanocortin 2 receptor; MC2R). Most of these mutations have not been functionally characterised at all, and those that have, have been incompletely assessed. Major difficulties have been encountered in functionally characterising normal or mutant MC2R owing to the requirement for an essential co-factor for MC2R expression. This lab has recently identified this factor known as the melanocortin 2 receptor accessory protein (MRAP). Combined expression of MC2R and MRAP therefore allows a detailed characterisation of the receptor to be conducted, and is predicted to reveal receptor mutations that affect ligand binding, signal transduction or receptor folding and trafficking. 

Design:
In vitro analysis of CHO and HEK 293 cells transfected with wild type or mutated MC2R plasmids using confocal imaging, ligand binding and cAMP signal generation. 

Methodology: 
CHO and HEK293 cell lines will be stably transfected with hMRAP cDNA and gene and protein expression confirmed by RT-PCR and immunoblotting. MC2R Transfected HEK293-MRAP cells will be used for ACTH ligand binding and receptor function will be determined using our in house cAMP assay. Mutations inserted into the MC2R-GFP vector will be transiently transfected into CHO-MRAP cells and imaged using laser scanning confocal microscopy. Absent or reduced GFP decoration of the plasma membrane will be confirmed by density gradient centrifugation and will identify those MC2R mutations that fail to traffic to the cell surface. These will be investigated for MRAP binding using co-immunoprecipitation of transfected HA-tagged MC2R and MRAP. 

Scientific medical opportunities:
This data will enable a model of the functional components of the MC2R to be developed and may reveal novel aspects of ACTH binding sites or MRAP interaction. 
 AA</gtr:technicalSummary><gtr:fund><gtr:end>2009-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>160375</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Society of endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DCF12BCC-B261-4C8D-8042-5810D6B0DBDE</gtr:id><gtr:impact>Lots of interest was received. The presentation won the poster prize of its category.

Peer reviewed publicatiions were produced</gtr:impact><gtr:outcomeId>UPScKXqnrz5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>pcDNA3.1 -Mrap stably transfected in HEK295 and CHO cell lines.</gtr:description><gtr:id>14063285-DF41-4262-A9FD-B703B0A9BBE0</gtr:id><gtr:impact>the cell line will be used in further studies in ACTH receptors</gtr:impact><gtr:outcomeId>ANtuWY7XfWq</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stable mrap expression in non-adrenal cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AF8C1AF7-CB8E-451E-B55B-6DB270B56749</gtr:id><gtr:title>Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f00f976db1ab8a325f5ad80b8f3adc7"><gtr:id>0f00f976db1ab8a325f5ad80b8f3adc7</gtr:id><gtr:otherNames>Hughes CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>G8W9Xsg8Yv8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A66B3E20-F061-40FF-8E3B-23469C7D6CBA</gtr:id><gtr:title>The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>325FBFFCE7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8D31853-3F61-4A4D-AB1F-D9B31ADCD7E3</gtr:id><gtr:title>No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>grY8iwWGqG1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EA32BBC-8094-421F-B7DB-DF42F3BA5D72</gtr:id><gtr:title>Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>64037A35D56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1370546E-4225-41C2-BF39-F7AEE2FC5128</gtr:id><gtr:title>Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>XZt7m8HG64G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90B24DDC-BC26-4722-875E-5593E6C19B55</gtr:id><gtr:title>MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>A9V9njiDAAm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>179CDA7E-1D66-488B-83F5-7967FB4FA1D3</gtr:id><gtr:title>The genetics of familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1cc2aa8d2d6d1ed6ad73bf575ba1f1f"><gtr:id>f1cc2aa8d2d6d1ed6ad73bf575ba1f1f</gtr:id><gtr:otherNames>Clark AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>SJpVhz7X2Fu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3019B91F-2D40-4B70-A447-B3D0B2B3101D</gtr:id><gtr:title>Bioluminescence resonance energy transfer reveals the adrenocorticotropin (ACTH)-induced conformational change of the activated ACTH receptor complex in living cells.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13f565af01e8b797b5e7db33536e446"><gtr:id>b13f565af01e8b797b5e7db33536e446</gtr:id><gtr:otherNames>Cooray SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_16030_20_21177829</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700581</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>